EVAX (Evaxion AS) EV-to-OCF: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVAX Evaxion AS EVAX
29 GF Score
Price $2.98
! 2 Warning Signs
View Full Analysis

What is Evaxion AS EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Evaxion AS's Enterprise Value is $9.12 Mil. Evaxion AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil. Therefore, Evaxion AS's EV-to-OCF for today is .

The historical rank and industry rank for Evaxion AS's EV-to-OCF or its related term are showing as below:

EVAX' s EV-to-OCF Range Over the Past 10 Years
Min: -1.44   Med: 0   Max: -1.14
Current: -1.38

During the past 9 years, the highest EV-to-OCF of Evaxion AS was -1.14. The lowest was -1.44. And the median was .

EVAX's EV-to-OCF is ranked worse than
61.99% of 1410 companies
in the Biotechnology industry
Industry Median: -3.475 vs EVAX: -1.38

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-06), Evaxion AS's stock price is $2.98. Evaxion AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.000. Therefore, Evaxion AS's PE Ratio (TTM) for today is At Loss.


Evaxion AS  (NAS:EVAX) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Evaxion AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.98/-2.000
=At Loss

Evaxion AS's share price for today is $2.98.
Evaxion AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Evaxion AS EV-to-OCF Related Terms


Evaxion AS EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Evaxion AS's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evaxion AS EV-to-OCF Chart

Evaxion AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only -3.38 -1.55 -1.85 -0.78 -3.63

Evaxion AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.63 0.00

EVAX vs CRVO, ALGS, TVRD: EV-to-OCF Comparison

For the Biotechnology subindustry, Evaxion AS's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evaxion AS EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion AS's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Evaxion AS's EV-to-OCF falls into.


EVAX
29GF Score
Evaxion AS EVAX
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evaxion AS EV-to-OCF Calculation

Evaxion AS's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=9.124/0
=

Evaxion AS's current Enterprise Value is $9.12 Mil.
Evaxion AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evaxion AS Business Description

Address Dr. Neergaards Vej 5f, Horsholm, DNK, 2970
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
29GF Score

Get the complete analysis for EVAX

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.98
Price